MMNFF - MedMen Enterprises Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
10/30/2017
6/29/2017
10/30/2016
Total Revenue
86,292
129,963
39,783
2
2,672
13
Cost of Revenue
47,917
69,086
25,933
4
1,804
8
Gross Profit
38,375
60,878
13,850
-2
868
5
Operating Expenses
Research Development
-
-
-
-
-
-
Selling General and Administrative
234,838
262,199
105,196
126
14,462
107
Total Operating Expenses
244,583
283,174
110,454
126
15,658
107
Operating Income or Loss
-206,208
-222,296
-96,603
-128
-14,789
-101
Interest Expense
21,837
22,817
16,115
0
512
0
Total Other Income/Expenses Net
-
-18,820
1,992
6
-73
0
Income Before Tax
-221,668
-263,232
-110,726
-123
-15,375
-102
Income Tax Expense
4,899
13,815
1,539
-
43
-
Income from Continuing Operations
-226,567
-277,047
-112,265
-123
-15,418
-102
Net Income
-81,469
-79,120
-66,647
-123
-15,418
-102
Net Income available to common shareholders
-81,469
-79,120
-66,647
-123
-15,418
-102
Reported EPS
Basic
-
-0.75
-1.65
-0.22
-26.33
-0.17
Diluted
-
-0.75
-1.65
-0.22
-26.33
-0.17
Weighted average shares outstanding
Basic
-
105,915
40,480
586
586
586
Diluted
-
105,915
40,480
586
586
586
EBITDA
-
-217,816
-88,580
-123
-13,221
-101